The objective of the course is to improve the ability of students to think, conceive, design, conduct, analyze and interpret research in molecular epidemiology that is highly valid, and highly relevant relevant either from a biological, from a clinical or from a public health perspective.
Miquel Porta is Head of Clinical & Molecular Epidemiology of Cancer Unit, Municipal Institute of Medical Research (IMIM).
Professor of Preventive Medicine & Public Health, School of Medicine, Universitat Autònoma de Barcelona (UAB).
Adjunct Professor, Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill (UNC).
After graduating from the UAB School of Medicine in 1981, he was during 3 years a Fellow with the Division of Clinical Pharmacology of UAB. He was then awarded a Fulbright scholarship to pursue the Master of Public Health (MPH) program at UNC, and was later a Burroughs Wellcome Postdoctoral Fellow in Pharmacoepidemiology at UNC.
Other than at the UAB School of Medicine, Dr. Porta has also taught on molecular epidemiology, clinical epidemiology and pharmacoepidemiology at other institutions, including McGill University (Montreal, Canada), the European Educational Programme in Epidemiology (Firenze, Italy), the Westfälische Wilhelms-Universität (Münster, Germany), several universities in Brazil and Mexico, and at Harvard, where he was on sabbatical in 1998-1999.
From 1994 to 1998 he was President of the Spanish Society of Epidemiology (SEE). From 2002 to 2005 he was European Councillor of the International Epidemiological Association (IEA) and Chairman of the IEA European Epidemiology Federation.